Check out Jio Platforms IPO GMP, also known as the IPO Grey Market Premium, along with Kostak rates and Subject to Sauda rates as of today. The Jio Platforms IPO GMP provides an unofficial indication of market sentiment ahead of the company’s stock market listing. Stay tuned to IPOWala for the latest Jio Platforms IPO GMP updates.

The Jio Platforms IPO GMP is subject to market fluctuations and may change frequently before listing. As of 16 October 2026, the reported GMP was ₹222 per share. Against the upper IPO price band of ₹1,119, this indicates an estimated listing price of ₹1,341 per share and an indicative premium of approximately 19.84%. These figures are unofficial and are not guaranteed listing returns.

The Jio Platforms IPO will open for subscription on 21 October 2026 and close on 23 October 2026. The company has fixed the IPO price band at ₹1,065–₹1,119 per share. The total IPO size is approximately ₹30,213 crore, making it one of India’s most anticipated public issues.

Jio Platforms IPO GMP Live Rates – Daily Grey Market Premium Updates

For complete IPO information, including the issue dates, price band, company review, financial performance, allotment details and listing date, visit the
Jio Platforms IPO Details on IPOWala.

Jio Platforms IPO GMP Today – Live Rates

The following table can be updated daily with the latest available Jio Platforms IPO GMP, Kostak rate and Subject to Sauda information. Please verify the latest figures before publishing.

Jio Platforms IPO Date, Price, GMP, Review and Details

Jio Platforms IPO Details

The Jio Platforms IPO price band, issue dates, issue size and other key details are mentioned below.

For updated details and official issue information, visit the Jio Platforms IPO page on IPOWala.

What Is Jio Platforms IPO GMP?

Jio Platforms IPO GMP means Jio Platforms IPO Grey Market Premium. It refers to the unofficial premium at which IPO shares are reportedly traded in the grey market before their stock exchange listing.

For example, if the IPO upper price band is ₹1,119 and the reported GMP is ₹222, the estimated listing price would be ₹1,341 per share. This is only an indicative calculation based on the reported GMP and does not guarantee the actual listing price or investor profit.

Jio Platforms IPO Expected Listing Price

These calculations are illustrative and based on the historical reported GMP. Actual GMP and listing performance can change, and listing may occur at a lower or higher price.

About Jio Platforms Limited

Jio Platforms Limited is a digital technology and connectivity company within the Reliance Industries group. Through Reliance Jio Infocomm Limited, the company provides mobile connectivity, broadband, enterprise connectivity and digital services to consumers and businesses.

Its business ecosystem includes 5G connectivity, JioFiber, AirFiber, cloud services, digital applications, entertainment and other technology-enabled offerings. The company’s large customer base and digital infrastructure are important factors investors may consider while evaluating the IPO.

Factors to Consider Before Investing in Jio Platforms IPO

• Business strength: Evaluate Jio’s digital services, connectivity business and competitive position.
• Financial performance: Review revenue, profitability, debt and cash flows disclosed in the offer documents.
• IPO valuation: Compare the issue valuation with the company’s financial performance and growth prospects.
• Market sentiment: GMP may reflect unofficial market expectations but can change rapidly.
• Listing risk: A high GMP does not ensure listing gains, and the share price may fall below the issue price.

Jio Platforms IPO GMP FAQs

Q. What is Jio Platforms IPO GMP today?

The latest GMP should be checked on the IPOWala IPO GMP Live Rates page. A reported figure of ₹222 was available for 16 October 2026; this is not a verified live quote for 19 October 2026.

Q. What is the Jio Platforms IPO Kostak rate today?

The latest Kostak rate should be confirmed from current market information. IPOWala will display a rate when reliable information is available.

Q. What is the Jio Platforms IPO Subject to Sauda rate today?

The current Subject to Sauda rate needs to be verified before publication. Please check the live IPO GMP page for available updates.

Q. What is the expected listing price of Jio Platforms IPO?

The indicative listing price is calculated by adding the reported GMP to the IPO price. For example, an upper price band of ₹1,119 and a GMP of ₹222 imply ₹1,341. This is an estimate, not a guaranteed listing price.

Q. When will Jio Platforms IPO open and close?

The Jio Platforms IPO is scheduled to open on 21 October 2026 and close on 23 October 2026, subject to the final issue schedule.

Q. Where can I check Jio Platforms IPO details?

Visit the Jio Platforms IPO Date, Price, GMP, Review and Details page on IPOWala for the latest available information.

Disclaimer

📌 Grey Market Premium (GMP) figures published on IPOWala.in are provided for news and informational purposes only.

🚫 IPOWala.in does not trade in, deal in, or support grey market or Subject to Sauda transactions.

⚠️ Do not invest in an IPO solely on the basis of GMP. Grey market premiums are unofficial, may be inaccurate and can change rapidly.

📊 Review the company’s financial statements, valuation, business model, risks and official offer documents before making an investment decision.

🧠 Consult a SEBI-registered investment adviser if you need personalised investment advice. IPOWala.in does not guarantee listing gains or investment returns and is not associated with grey market operators.

“`

The post Jio Platforms IPO GMP Today, Grey Market Premium 2026 appeared first on IPO Wala.

The Jio Platforms IPO is scheduled to open for subscription on 21-October-2026 and close on 23-October-2026. The IPO has a price band of ₹1,065 to ₹1,119 per share and is expected to be one of India’s largest IPOs. Investors can apply through their broker, UPI or the ASBA facility available through participating banks.

Jio Platforms IPO Application Form Download

Investors who want to apply using a physical IPO application form can download the Jio Platforms IPO Application Form from the official NSE or BSE IPO form portals, when the issue is available for application.

Download Jio Platforms IPO Form

How to Download Jio Platforms IPO Form from BSE?

1. Open the BSE IPO Application Form page.
2. Select Jio Platforms from the available IPO list.
3. Select the required Category Type, Repatriation Type and number of forms.
4. Enter the Captcha Code.
5. Click on Download Application Form.
6. Check your Downloads folder for the downloaded form.

How to Download Jio Platforms IPO Form from NSE?

1. Open the NSE IPO Application Form page.
2. Find and select Jio Platforms from the IPO list.
3. Select Blank Application Form Download.
4. Select your Investor Status, Bid From Type and the number of forms required.
5. Enter the Captcha Code.
6. Accept the applicable terms and conditions.
7. Click Download to save the Jio Platforms IPO application form.

How to Apply for Jio Platforms IPO?

Investors can apply for the Jio Platforms IPO through their supported broker using UPI or through the ASBA facility provided by participating banks. Eligible Reliance Industries shareholders may also have access to the shareholder reservation, subject to the applicable eligibility requirements.

Before submitting an application, investors should check the latest IPO price, lot size, reservation details and application dates.

Jio Platforms IPO Important Details

Jio Platforms IPO – More Details

Check the complete Jio Platforms IPO Date, Price, GMP, Review and Details on IPOWala for the latest IPO information, subscription status, GMP, allotment date and listing details.

You can also check the latest IPO Application Forms for other upcoming IPOs.

FAQs – Jio Platforms IPO Application Form

Where can I download the Jio Platforms IPO application form?

You can download the application form through the official BSE or NSE IPO form portals when the Jio Platforms IPO form is available.

Can I apply for Jio Platforms IPO through ASBA?

Yes. Investors can apply through the ASBA facility provided by participating banks.

Can I apply for Jio Platforms IPO using UPI?

Yes. Eligible investors can apply through supported broker platforms using the UPI application process.

What is the Jio Platforms IPO price band?

The Jio Platforms IPO price band is ₹1,065 to ₹1,119 per share.

Disclaimer: IPO application methods, forms and issue details may change. Investors should verify the latest information on the official exchange and issue documents before applying.

The post Jio Platforms IPO Application Form Download – NSE & BSE appeared first on IPO Wala.

There are three basic categories in Paras Healthcare IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail Investors.

Paras Healthcare Limited is a clinical specialty-led healthcare provider offering tertiary and quaternary healthcare services under the Paras Health brand. The company operates hospitals across North India, Bihar and Jharkhand and focuses on specialties including cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and sports injury, and renal sciences.

As of 31-March-2026, Paras Healthcare operated eight hospitals with an aggregate capacity of 2,211 beds across Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar. The company plans to expand its hospital network with a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana, taking its expected total bed capacity to approximately 3,011 beds by March 2028.

Paras Healthcare IPO Promoters

Dr. Dharminder Kumar Nagar is the promoter of Paras Healthcare Limited. The promoter held approximately 72.8% of the company before the IPO, according to available offer-document information.

Paras Healthcare IPO Date, Details & Price Band

The Paras Healthcare IPO Price Band, IPO Dates, Market Lot and other important details are mentioned in the table below.

The Paras Healthcare IPO comprises a ₹500 crore fresh issue and an offer for sale of ₹950 crore, aggregating to ₹1,450 crore. The equity shares are proposed to be listed on both the NSE and BSE.

Paras Healthcare IPO Market Lot

The Paras Healthcare IPO minimum market lot is 21 shares. At the upper price band of ₹693 per share, the minimum application amount is ₹14,553.

Paras Healthcare IPO: Object of the Issue

The company proposes to utilise the proceeds from the fresh issue primarily for debt-related purposes and general corporate purposes.

• Prepayment or scheduled repayment, in full or part, of certain outstanding borrowings availed by the company.
• Investment in its wholly owned subsidiary, Paras Medicare Hospital Private Limited (PMHPL), for repayment or prepayment of borrowings related to the Srinagar hospital.
• General corporate purposes.

The company had proposed using a substantial portion of the fresh issue proceeds toward reducing debt, including borrowings at the subsidiary level.

Restated Consolidated Financial Information (Amt. in Crore)

Paras Healthcare’s consolidated revenue increased to approximately ₹1,628.78 crore in FY2026 from ₹1,314.21 crore in FY2025, while the company reported a profit after tax of ₹43.83 crore in FY2026 compared with losses in the preceding two years.

Paras Healthcare IPO GMP & Grey Market Premium

The Paras Healthcare IPO GMP (Grey Market Premium) is being tracked in the unofficial grey market. Check the latest Paras Healthcare IPO GMP, Kostak Rates and Subject to Sauda Price here.

Note: IPO GMP is an unofficial market indicator and is not regulated or guaranteed by SEBI, NSE or BSE. GMP can change frequently before listing. As of 16-October-2026, available market trackers were reporting GMP around ₹83–₹97 per share.

Paras Healthcare IPO Prospectus

The Paras Healthcare IPO Prospectus is available through the company’s offer documents and regulatory filings. Please click here to download the Paras Healthcare IPO Prospectus.

Paras Healthcare IPO Allotment Date & Details

The tentative IPO schedule indicates allotment on 26-October-2026 and listing on 28-October-2026 on the NSE and BSE.

Registrar of Paras Healthcare IPO

MUFG Intime India Private Limited

The Registrar to the Paras Healthcare IPO is MUFG Intime India Private Limited. The registrar will be responsible for processing IPO applications, allotment and refund-related activities.

Paras Healthcare Contact Details

Paras Healthcare Limited

Gurugram, Haryana, India

Website: www.parashealthcare.com

Paras Healthcare IPO Lead Managers

JM Financial Limited

BofA Securities India Limited

Nuvama Wealth Management Limited

These three investment banking firms are the book-running lead managers for the Paras Healthcare IPO.

Paras Healthcare IPO Important Highlights

• IPO Open Date: 21-October-2026
• IPO Close Date: 23-October-2026
• Price Band: ₹660–₹693 per share
• Issue Size: ₹1,450 Crores
• Fresh Issue: ₹500 Crores
• Offer for Sale: ₹950 Crores
• Lot Size: 21 Shares
• Minimum Investment: ₹14,553
• Listing: NSE & BSE
• Allotment Date: 26-October-2026
• Listing Date: 28-October-2026
• Registrar: MUFG Intime India Private Limited
• Lead Managers: JM Financial, BofA Securities India and Nuvama Wealth Management

The post Paras Healthcare IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

The Bonfiglioli Transmissions IPO is entirely an Offer for Sale (OFS) of up to 4,32,39,042 Equity Shares by the existing promoter, Bonfiglioli S.p.A. There is no fresh issue in this IPO. The IPO is a Book Built Issue and the shares will be listed on the NSE and BSE.

There are three basic categories in Bonfiglioli Transmissions IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail Individual Investors.

Bonfiglioli Transmissions Limited is an engineering company engaged in the design, manufacture and supply of gearboxes, geared motors, planetary gearboxes, drive systems and other power transmission solutions. The company serves industries including wind energy, construction machinery, mobile equipment, industrial automation, material handling and other industrial applications.

Bonfiglioli Transmissions is part of the global Bonfiglioli Group, an Italian engineering group specialising in power transmission and motion solutions. The company operates manufacturing facilities and serves customers across several industrial sectors.

Bonfiglioli Transmissions IPO Promoters

The promoters of the company are Sonia Bonfiglioli, Luciano Bonfiglioli, Luisa Lusardi, Bon-FI S.R.L. and Bonfiglioli S.P.A. The promoter group holds 100% of the company before the IPO. After the IPO, the promoter holding is expected to reduce as a result of the OFS.

Bonfiglioli Transmissions IPO Date, Details & Price Band

The Bonfiglioli Transmissions IPO Price Band, IPO Dates, Market Lot and other details are mentioned in the table below.

The IPO consists entirely of an Offer for Sale. Therefore, the proceeds from the OFS will go to the selling shareholder rather than being received by Bonfiglioli Transmissions Limited.

Bonfiglioli Transmissions IPO Market Lot

The Bonfiglioli Transmissions IPO minimum market lot is 25 shares. At the upper price band of ₹586 per share, the minimum retail application amount is ₹14,650.

Bonfiglioli Transmissions IPO Reservation

The retail portion represents approximately 35% of the offered shares, while the QIB portion is approximately 20% excluding the anchor allocation. An employee reservation of 50,000 shares is also included.

Bonfiglioli Transmissions IPO Business Overview

Bonfiglioli Transmissions Limited is engaged in the manufacture and supply of power transmission and motion-control solutions. Its product portfolio includes gearboxes, geared motors, planetary gearboxes and drive systems.

The company’s products are used across several industries, including wind energy, construction equipment, mobile machinery, industrial automation, material handling and other industrial applications.

The company benefits from its association with the global Bonfiglioli Group, which provides access to global technology, engineering capabilities and international customer relationships.

Bonfiglioli Transmissions IPO Financial Performance

The company’s financial performance has shown growth over the reported periods. FY2025 revenue stood at approximately ₹2,013.53 Crores, while Profit After Tax was approximately ₹237.87 Crores.

Bonfiglioli Transmissions IPO Latest Financial Performance

For the six-month period ended 30-June-2026, Bonfiglioli Transmissions reported revenue of approximately ₹1,131.87 Crores, EBITDA of approximately ₹231.17 Crores and Profit After Tax of approximately ₹148.58 Crores.

The six-month FY2026 figures show improvement compared with the corresponding period of the previous year, with revenue increasing from ₹960.36 Crores to ₹1,131.87 Crores and PAT increasing from ₹114.97 Crores to ₹148.58 Crores.

Bonfiglioli Transmissions IPO Strengths

• Strong industrial presence: The company operates in the power transmission and motion-control industry with applications across multiple industrial sectors.
• Global Bonfiglioli Group association: The company benefits from the technology, engineering expertise and global presence of the Bonfiglioli Group.
• Diversified end-use industries: Its products are used in wind energy, construction, mobile machinery, industrial automation and material handling.
• Improving financial performance: Revenue and profit increased during the six months ended June 2026 compared with the corresponding period of the previous year.
• Strong profitability: The company reported FY2025 EBITDA of approximately ₹380.83 Crores and PAT of approximately ₹237.87 Crores.
• Debt position: The company had no reported total borrowings in the financial periods shown in the IPO data.

Bonfiglioli Transmissions IPO Risks

• Entirely an OFS: The company will not receive proceeds from the Offer for Sale, as the shares are being sold by the existing promoter.
• Promoter concentration: The promoter group has complete ownership before the IPO, resulting in significant promoter influence after listing.
• Industrial cyclicality: Demand for power transmission products can be affected by industrial investment cycles and capital expenditure trends.
• Customer concentration: Dependence on major customers and specific industries may affect revenue if demand from those sectors weakens.
• Raw material risk: Changes in the prices of steel and other key raw materials can affect manufacturing margins.
• Foreign currency exposure: International operations and transactions may expose the company to foreign exchange fluctuations.
• Competition: The company operates in a competitive global power transmission and industrial equipment market.
• Valuation risk: Investors should evaluate the IPO valuation against earnings, peers and future growth prospects rather than relying only on the grey market premium.

Bonfiglioli Transmissions IPO GMP & Grey Market Premium

The Bonfiglioli Transmissions IPO GMP (Grey Market Premium) represents the premium at which IPO shares are reportedly being traded in the unofficial grey market before listing.

As of 15-October-2026, the latest reported GMP was around ₹162 per share. Against the upper IPO price of ₹586, this indicates an indicative listing price of approximately ₹748 per share, representing an unofficial premium of around 27.65%.

Other market sources reported GMP levels in the range of approximately ₹162–₹181 during the day. GMP can change rapidly and is an unofficial indicator; it should not be treated as a guaranteed listing price or listing gain.

At a GMP of ₹162, the indicative gain for one retail lot of 25 shares would be approximately ₹4,050.

Check the latest Bonfiglioli Transmissions IPO GMP, Kostak Rates and Subject to Sauda Price here.

Bonfiglioli Transmissions IPO Subscription Status

The Bonfiglioli Transmissions IPO opened for subscription on 15-October-2026 and will close on 19-October-2026.

As of the latest available subscription update on 15-October-2026, the IPO had received mixed demand across investor categories.

Subscription figures are live-market data and can change throughout the IPO bidding period. The above figures represent a latest available snapshot and should be refreshed on the page as exchange data changes.

Bonfiglioli Transmissions IPO Prospectus

The Bonfiglioli Transmissions IPO Draft Red Herring Prospectus was filed with SEBI. The company’s registered and corporate office is located at Plot No. AC7-AC11, SIDCO Industrial Estate, Thirumudivakkam, Kancheepuram, Tamil Nadu – 600132.

Please click here to Download the Bonfiglioli Transmissions IPO Prospectus.

Bonfiglioli Transmissions IPO Allotment Date & Details

The current IPO timetable indicates allotment on 21-October-2026, refund and demat credit on 22-October-2026, and listing on 23-October-2026.

Bonfiglioli Transmissions IPO Registrar

MUFG Intime India Private Limited

C-101, 1st Floor, 247 Park,
Lal Bahadur Shastri Marg,
Vikhroli (West),
Mumbai – 400083,
Maharashtra, India

Tel: +91-22-4918 6270

Website: www.in.mpms.mufg.com

Registrar: MUFG Intime India Private Limited

Bonfiglioli Transmissions IPO Contact Address

Bonfiglioli Transmissions Limited

Registered & Corporate Office:
Plot No. AC7-AC11,
SIDCO Industrial Estate,
Thirumudivakkam,
Kancheepuram – 600132,
Tamil Nadu, India

Contact Person: Sunil Kumar, Company Secretary and Compliance Officer

Phone: +91 63858 63934

Email: btl.secretarial@bonfiglioli.com

Website: www.bonfiglioli.in

Bonfiglioli Transmissions IPO Lead Managers

ICICI Securities Limited

The post Bonfiglioli Transmissions IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

The Sahajanand Medical Technologies IPO is a mainboard public issue of Sahajanand Medical Technologies Limited, a medical technology company engaged in the development and manufacturing of cardiovascular medical devices. The company focuses primarily on vascular intervention and structural heart devices, including coronary drug-eluting stents, balloon catheters, transcatheter aortic valve implantation (TAVI) systems and occluders.

The Sahajanand Medical Technologies IPO opened for subscription on 15-October-2026 and will close on 19-October-2026. The IPO comprises an Offer for Sale (OFS) of up to 1,38,22,116 equity shares. There is no fresh issue, meaning the company will not receive any proceeds from the IPO. Investors can use this page to check the Sahajanand Medical Technologies IPO date, price band, market lot, IPO size, GMP, allotment date, subscription details and listing information.

Sahajanand Medical Technologies operates in the specialised cardiovascular medical device industry and markets its products across 77 countries, including India. Its products are used in minimally invasive cardiovascular procedures and include coronary stents, balloons, structural heart devices and other specialised medical products.

Sahajanand Medical Technologies IPO Promoters

Bhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen and Shree Hari Trust are the promoters of Sahajanand Medical Technologies Limited. The company was founded in 2001 and is headquartered in Surat, Gujarat.

Sahajanand Medical Technologies Business Overview

Sahajanand Medical Technologies Limited is a medical technology company focused on cardiovascular devices. The company’s product portfolio covers both Vascular Intervention and Structural Heart applications.

The company develops and manufactures medical devices used in minimally invasive cardiovascular procedures. Its major products include drug-eluting coronary stents, balloon catheters, TAVI systems, occluders, renal stents and peripheral drug-coated balloons.

Vascular Intervention Devices

Vascular Intervention is the company’s largest business segment. It contributed approximately 61.14% of revenue from operations in FY2026, generating approximately ₹740.09 Crores of revenue.

The company’s Vascular Intervention portfolio includes coronary drug-eluting stents and balloon catheters. The Supraflex family, including Supraflex Cruz, is an important part of the company’s coronary stent portfolio.

According to the Frost & Sullivan report cited in the RHP, Sahajanand Medical Technologies held approximately 25% of India’s drug-eluting stent market by sales volume in FY2026. The company was also among the top five DES companies by sales volume in Germany, Spain, Poland and Brazil.

Structural Heart Devices

Structural Heart is another important business segment of Sahajanand Medical Technologies. It contributed approximately 16.77% of revenue from operations in FY2026.

The company’s Structural Heart portfolio includes Hydra, a transcatheter aortic valve implantation (TAVI) system, and Cocoon, a range of occluder devices used in selected structural heart procedures.

The contribution of Structural Heart products has increased from approximately 12.26% of revenue in FY2024 to 16.77% in FY2026, indicating the company’s increasing diversification beyond its core coronary stent business.

Other Medical Devices

The company’s other products include renal stents, peripheral drug-coated balloons and certain traded medical devices. This category accounted for approximately 22.09% of revenue from operations in FY2026.

Sahajanand Medical Technologies IPO Date, Details & Price Band

The Sahajanand Medical Technologies IPO price band, IPO dates, issue size, face value and other important details are provided in the table below.

Sahajanand Medical Technologies IPO Market Lot

The Sahajanand Medical Technologies IPO minimum market lot is 43 shares. Based on the upper price band of ₹344 per share, one retail lot requires an application amount of ₹14,792.

Retail investors can apply for a minimum of one lot and a maximum of 13 lots. Bids can be made in multiples of 43 shares. Up to 2,50,000 equity shares are reserved for eligible employees.

Sahajanand Medical Technologies IPO: Objects of the Issue

The Sahajanand Medical Technologies IPO is entirely an Offer for Sale (OFS). The issue consists of up to 1,38,22,116 equity shares being offered by existing shareholders.

Since there is no fresh issue of shares, Sahajanand Medical Technologies Limited will not receive any proceeds from the IPO. The proceeds from the offer, after applicable offer expenses, will accrue to the selling shareholders.

The selling shareholders include Shree Hari Trust, Dhirajkumar Savjibhai Vasoya, Samara Capital Markets Holding Limited, NHPEA Sparkle Holding B.V. and Kotak Pre-IPO Opportunities Fund.

Sahajanand Medical Technologies Financial Performance

Sahajanand Medical Technologies has reported consistent growth in revenue from operations over the last three financial years. Revenue increased from ₹901.60 Crores in FY2024 to ₹1,024.88 Crores in FY2025 and further to ₹1,210.50 Crores in FY2026.

The company also returned to profitability. Profit after tax improved from a loss of ₹7.35 Crores in FY2024 to a profit of ₹25.15 Crores in FY2025 and ₹69.08 Crores in FY2026.

EBITDA increased from ₹110.05 Crores in FY2024 to ₹128.02 Crores in FY2025 and ₹170.66 Crores in FY2026, while the EBITDA margin improved to approximately 14.10% in FY2026.

Sahajanand Medical Technologies Latest Quarterly Performance

For the quarter ended 30-June-2026, Sahajanand Medical Technologies reported total income of approximately ₹354.33 Crores and profit after tax of approximately ₹15.09 Crores. EBITDA for the quarter was approximately ₹48.58 Crores.

Sahajanand Medical Technologies IPO Strengths

Sahajanand Medical Technologies operates in a specialised medical-device segment with a growing product portfolio, international presence and established research and development capabilities.

• Strong cardiovascular product portfolio: The company manufactures coronary stents, balloon catheters, TAVI systems, occluders, renal stents and peripheral drug-coated balloons.
• Strong position in Indian DES market: According to the Frost & Sullivan report cited in the RHP, the company held approximately 25% of India’s drug-eluting stent market by sales volume in FY2026.
• Global presence: The company marketed its products in 77 countries in FY2026, with international markets contributing approximately 73.87% of revenue from operations.
• Growing Structural Heart business: Structural Heart revenue contribution increased to 16.77% in FY2026 from 12.26% in FY2024.
• Improving profitability: PAT increased from a loss of ₹7.35 Crores in FY2024 to ₹69.08 Crores in FY2026.
• Strong R&D capabilities: The company had 119 granted patents globally, 78 pending patent applications and five design registrations as of the RHP date.
• Clinical research: As of 30-June-2026, the company’s products were supported by 75 clinical studies, including completed and ongoing studies.
• Integrated manufacturing: The company operates three manufacturing facilities and has in-house capabilities covering areas such as balloon catheter production, laser cutting, electropolishing, drug and polymer coating and valve manufacturing.

Sahajanand Medical Technologies IPO Risks

Investors should carefully evaluate the risks disclosed in the company’s RHP before applying for the IPO. Although the company has demonstrated revenue and profit growth, its business remains exposed to product concentration, international markets, regulatory requirements and supply-chain risks.

• Product concentration: Vascular Intervention devices contributed approximately 61.14% of revenue from operations in FY2026. The Supraflex Cruz product alone contributed approximately 37.17% of FY2026 revenue.
• Dependence on imported materials: Imports represented approximately 77.18% of total purchases in FY2026, exposing the company to foreign exchange, import restrictions and supply-chain risks.
• International revenue exposure: Approximately 73.87% of revenue from operations came from customers outside India in FY2026. Changes in foreign exchange rates, international regulations or overseas demand could affect performance.
• Supplier concentration: The company’s top 10 suppliers accounted for approximately 59.15% of purchases in FY2026. The company also depends on certain suppliers for critical materials.
• Regulatory risks: Medical devices are subject to regulatory approvals and quality standards in different countries. Delays or failure in obtaining regulatory approvals can affect product launches and sales.
• Working capital requirements: The company’s operations require significant working capital, which may affect cash flows and liquidity.
• Research and development risk: The company invests significantly in R&D, and unsuccessful product development or delays in regulatory approval could affect returns on these investments.

Sahajanand Medical Technologies IPO GMP & Grey Market Premium

The Sahajanand Medical Technologies IPO GMP (Grey Market Premium) represents the premium at which the IPO is reportedly being traded in the unofficial grey market. GMP can change frequently depending on IPO demand, subscription levels, market sentiment and broader market conditions.

As of 15-October-2026, the reported GMP was approximately ₹41 per share. Against the upper IPO price of ₹344, this indicates an unofficial estimated listing price of approximately ₹385 per share, representing an indicative premium of around 11.92%.

At a GMP of ₹41, the indicative premium for one retail lot of 43 shares would be approximately ₹1,763. However, GMP is unofficial and should not be treated as a guaranteed listing gain or listing price.

Check the latest Sahajanand Medical Technologies IPO GMP, Kostak Rate and Subject to Sauda information before making an investment decision.

Sahajanand Medical Technologies IPO Subscription Status

The Sahajanand Medical Technologies IPO opened for subscription on 15-October-2026. As of approximately 3:54 PM on 15-October-2026, the issue was reported to be subscribed around 0.30 times overall.

Subscription figures can change throughout the bidding period. Investors should check the latest category-wise subscription data before making an application decision.

Sahajanand Medical Technologies IPO Review

The Sahajanand Medical Technologies IPO provides investors exposure to the specialised cardiovascular medical device industry. The company has an established portfolio of coronary stents, balloon catheters and structural heart devices, along with a growing international presence.

The company has demonstrated improving financial performance, with revenue from operations increasing to ₹1,210.50 Crores in FY2026 and PAT improving to ₹69.08 Crores. EBITDA also increased to ₹170.66 Crores, with the EBITDA margin reaching approximately 14.10%.

However, investors should consider the company’s dependence on Vascular Intervention products, particularly Supraflex Cruz, as well as its high international revenue exposure and dependence on imported raw materials and components.

The IPO is also entirely an Offer for Sale. Therefore, the company will not receive new capital from the IPO for business expansion, debt repayment or other corporate purposes.

At the upper price band of ₹344, the company is valued at approximately ₹3,496.65 Crores. Based on FY2026 diluted EPS of approximately ₹6.48, the IPO valuation represents a P/E multiple of roughly 53 times, which should be evaluated against the company’s growth prospects and listed medical-device peers.

The final IPO decision should be based on the company’s financial performance, valuation, product portfolio, international expansion, competitive position, regulatory risks, supply-chain exposure and prevailing market conditions rather than GMP alone.

Sahajanand Medical Technologies IPO Prospectus

The Sahajanand Medical Technologies IPO Prospectus contains detailed information about the company’s business, financial performance, risk factors, promoters, management, selling shareholders, legal matters and IPO structure. Investors should read the RHP carefully before applying for the issue.

Sahajanand Medical Technologies IPO Allotment Date & Details

After the IPO closes, the registrar will process the basis of allotment. Investors can check their application status through the registrar’s website once the allotment process is completed.

Sahajanand Medical Technologies IPO Registrar

MUFG Intime India Private Limited is the registrar for the Sahajanand Medical Technologies IPO. The registrar is responsible for processing IPO applications, maintaining application records and handling the allotment process.

Website: www.in.mpms.mufg.com

Sahajanand Medical Technologies IPO Contact Address

Sahajanand Medical Technologies Limited

Corporate Office: 402 & 412, A-Wing, Kanakia Wall Street, Andheri-Kurla Road, Chakala, Andheri (East), Mumbai, Maharashtra – 400093, India

Telephone: 022 49564000

Investor Grievance Email: investors.grievance@smt.in

Sahajanand Medical Technologies IPO Lead Managers

The book running lead managers to the Sahajanand Medical Technologies IPO are:

• Motilal Oswal Investment Advisors Limited
• Avendus Capital Private Limited
• HSBC Securities and Capital Markets (India) Private Limited
• Nuvama Wealth Management Limited

MUFG Intime India Private Limited is acting as the registrar to the issue.

Sahajanand Medical Technologies IPO FAQs

When is the Sahajanand Medical Technologies IPO opening date?

The Sahajanand Medical Technologies IPO opened for subscription on 15-October-2026 and will close on 19-October-2026.

What is the Sahajanand Medical Technologies IPO price band?

The Sahajanand Medical Technologies IPO price band is ₹327 to ₹344 per share.

What is the minimum lot size of the Sahajanand Medical Technologies IPO?

The minimum application lot is 43 shares, requiring ₹14,792 at the upper price band of ₹344 per share.

What is the Sahajanand Medical Technologies IPO size?

The Sahajanand Medical Technologies IPO size is approximately ₹475.48 Crores. The issue consists entirely of an Offer for Sale (OFS) of up to 1,38,22,116 equity shares.

Is Sahajanand Medical Technologies IPO a fresh issue or OFS?

The Sahajanand Medical Technologies IPO is a 100% Offer for Sale (OFS). The company is not issuing any new shares and therefore will not receive proceeds from the IPO.

What is the latest Sahajanand Medical Technologies IPO GMP?

As of 15-October-2026, the reported GMP was approximately ₹41 per share. Against the upper issue price of ₹344, this indicates an unofficial estimated listing price of approximately ₹385. GMP is unofficial and can change before listing.

What is the latest Sahajanand Medical Technologies IPO subscription status?

As of approximately 3:54 PM on 15-October-2026, the issue was reported to be subscribed around 0.30 times overall. QIB subscription was 0.37x, NII subscription was 0.14x and retail subscription was 0.33x at that time.

What is the Sahajanand Medical Technologies IPO allotment date?

The tentative basis of allotment date is 21-October-2026.

When will Sahajanand Medical Technologies IPO shares be listed?

The Sahajanand Medical Technologies shares are expected to be listed on the NSE and BSE on 23-October-2026.

Where can I check Sahajanand Medical Technologies IPO allotment status?

Investors can check the Sahajanand Medical Technologies IPO allotment status through the official website of MUFG Intime India Private Limited, the registrar to the issue, after the basis of allotment is finalized.

Is Sahajanand Medical Technologies IPO GMP reliable?

No. IPO GMP is an unofficial market indicator and can change frequently. Investors should not consider GMP as a guaranteed indication of the actual listing price or listing gain.

Is Sahajanand Medical Technologies profitable?

Yes. The company reported a profit after tax of ₹69.08 Crores in FY2026, compared with ₹25.15 Crores in FY2025 and a loss of ₹7.35 Crores in FY2024.

What are the main products of Sahajanand Medical Technologies?

The company’s major products include coronary drug-eluting stents, balloon catheters, TAVI systems, occluders, renal stents and peripheral drug-coated balloons.

How many countries does Sahajanand Medical Technologies operate in?

Sahajanand Medical Technologies marketed its products in 77 countries, including India, during FY2026.

The post Sahajanand Medical Technologies IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

The Zetwerk Manufacturing Businesses IPO is a mainboard public issue of Zetwerk Manufacturing Businesses Limited, a technology-led manufacturing company serving industrial and consumer product businesses in India and international markets. The company operates a manufacturing platform that combines its own manufacturing facilities with a large network of third-party suppliers. Its business covers energy products, precision products, capital goods and industrial commodities.

The Zetwerk Manufacturing Businesses IPO opened for subscription on 15-October-2026 and will close on 19-October-2026. The IPO comprises a fresh issue of approximately ₹2,830 Crores and an offer for sale of approximately ₹2,182.33 Crores, taking the total issue size to approximately ₹5,012.33 Crores. Investors can use this page to check the Zetwerk IPO date, price band, market lot, IPO size, GMP, allotment date, subscription details and listing information.

Zetwerk serves customers across several industries, including renewable energy, utilities, consumer electronics, artificial intelligence infrastructure, aerospace, space and defence, oil and gas and industrial automation. The company’s customers include businesses such as Siemens Gamesa, Acer India, the Indian Air Force and NTPC Renewable Energy.

Zetwerk Manufacturing Businesses IPO Promoters

Amrit Pratik Acharya and Srinath Ramakkrushnan are the promoters of Zetwerk Manufacturing Businesses Limited. Amrit Pratik Acharya is the company’s Managing Director, Chairman and Chief Executive Officer, while Srinath Ramakkrushnan is an Executive Director and Chief Operating Officer.

Zetwerk Manufacturing Businesses Overview

Zetwerk Manufacturing Businesses Limited is a technology-led manufacturing platform focused on industrial and consumer products. The company combines its own manufacturing facilities with a network of third-party suppliers to provide manufacturing capacity to customers.

The company has evolved from an asset-light manufacturing marketplace into a broader manufacturing platform with its own plants. As of 31-March-2026, Zetwerk had 26 of its own manufacturing facilities across India, Spain, Germany and the United States, supported by approximately 6,979 third-party suppliers across 26 countries.

Zetwerk’s business is divided into two major segments: the Manufacturing Business and the Ecosystem Business.

Manufacturing Business

The Manufacturing Business supplies industrial and consumer products through three principal verticals: Energy Products, Precision Products and Capital Goods. The company also provides original design manufacturing for certain products and components.

In FY2026, the Manufacturing Business generated approximately ₹9,374.68 Crores of revenue from operations from continuing operations and accounted for approximately 58.91% of the company’s revenue from operations from continuing operations.

• Energy Products: ₹6,507.57 Crores revenue in FY2026
• Precision Products: ₹1,397.19 Crores revenue in FY2026
• Capital Goods: ₹1,464.40 Crores revenue in FY2026

Ecosystem Business – Terra91

The company’s Ecosystem Business operates under the Terra91 brand. It sources industrial commodities such as ferrous and non-ferrous metals and petrochemicals and supplies these products to customers as a principal.

The Ecosystem Business generated approximately ₹6,538.65 Crores of revenue from operations from continuing operations in FY2026, representing approximately 41.09% of revenue from operations from continuing operations.

Zetwerk Manufacturing Businesses IPO Date, Details & Price Band

The Zetwerk IPO price band, IPO dates, issue size, face value and other important details are provided in the table below.

Zetwerk Manufacturing Businesses IPO Market Lot

The Zetwerk Manufacturing Businesses IPO minimum market lot is 99 shares. Based on the upper price band of ₹151 per share, one retail lot requires an application amount of ₹14,949.

Retail investors can apply for a minimum of one lot and a maximum of 13 lots. Bids can be made in multiples of 99 shares. Eligible employees are entitled to a discount of ₹14 per share.

Zetwerk Manufacturing Businesses IPO: Objects of the Issue

The fresh issue proceeds from the Zetwerk IPO will primarily be used for repayment or prepayment of borrowings and for funding the company’s inorganic growth plans.

• ₹1,250 Crores: Repayment or prepayment of certain borrowings of the company.
• ₹550 Crores: Repayment or prepayment of borrowings of nine subsidiaries through investment in those subsidiaries.
• Inorganic Growth: Funding unidentified acquisitions and other strategic acquisitions.
• General Corporate Purposes: A portion of the proceeds may be used for general corporate purposes.

The offer for sale component will result in existing shareholders selling their shares. Proceeds from the OFS will accrue to the selling shareholders and will not be received by the company.

Zetwerk Manufacturing Businesses Financial Performance

Zetwerk has reported strong growth in revenue, but the company remains loss-making. Revenue from operations increased from ₹12,364.37 Crores in FY2024 to ₹15,913.32 Crores in FY2026. However, the company reported a restated loss after tax of ₹1,606.17 Crores in FY2026.

The company’s loss after tax was ₹917.95 Crores in FY2024 and ₹370.71 Crores in FY2025 before increasing significantly to ₹1,606.17 Crores in FY2026.

Zetwerk Manufacturing Businesses IPO Latest Quarterly Performance

For the quarter ended 30-June-2026, Zetwerk reported revenue from operations of approximately ₹4,118 Crores, representing growth of more than 55% compared with the corresponding period of the previous year.

The company’s restated loss from continuing operations narrowed to approximately ₹64.13 Crores for the quarter, compared with a much larger loss in the corresponding period of the previous year.

Zetwerk Manufacturing Businesses IPO Strengths

Zetwerk operates across multiple manufacturing categories and has developed a large manufacturing ecosystem serving customers in several industrial sectors.

• Diversified manufacturing platform: Zetwerk operates across energy products, precision products, capital goods and industrial commodities.
• Large manufacturing network: The company had 26 own manufacturing facilities and approximately 6,979 third-party suppliers across 26 countries as of 31-March-2026.
• Strong manufacturing order book: The manufacturing order book stood at approximately ₹12,370.01 Crores as of 31-March-2026, compared with ₹8,628.98 Crores a year earlier.
• Exposure to high-growth sectors: The company has significant exposure to renewable energy, electronics, EVs, aerospace, defence, AI infrastructure and other industrial sectors.
• International presence: Zetwerk has manufacturing facilities and business operations across India, the United States and other international markets.
• Strong recent revenue growth: Revenue from operations increased substantially in FY2026, while the June 2026 quarter also recorded strong year-on-year revenue growth.
• Repeat customers: The company has reported a high proportion of repeat business, which can help support customer relationships and revenue visibility.

Zetwerk Manufacturing Businesses IPO Risks

Investors should carefully evaluate the risks disclosed in the company’s RHP before applying for the IPO. Although Zetwerk has achieved substantial revenue growth, the company continues to report losses and negative operating cash flows.

• Continued losses: The company reported a restated loss of ₹1,606.17 Crores in FY2026.
• Negative operating cash flow: The company has reported negative cash flow from operating activities for multiple years.
• Increasing borrowings: Total borrowings increased to approximately ₹1,936.16 Crores as of 31-March-2026 from ₹1,232.10 Crores in FY2024.
• Customer concentration: The top 10 customers accounted for a significant portion of revenue from continuing operations in FY2026.
• Low profitability: Despite substantial revenue, the company has not yet demonstrated consistent net profitability.
• Raw material and pricing risks: Manufacturing operations are exposed to fluctuations in raw material prices, supply-chain conditions and customer pricing pressure.
• Dependence on key sectors: A substantial portion of revenue is generated from energy-related products, making the company exposed to developments in renewable energy and infrastructure spending.

Zetwerk Manufacturing Businesses IPO GMP & Grey Market Premium

The Zetwerk Manufacturing Businesses IPO GMP (Grey Market Premium) represents the premium at which the IPO is reportedly being traded in the unofficial grey market. GMP can change frequently depending on IPO demand, subscription levels, market sentiment and broader market conditions.

As of 15-October-2026, reports indicated a GMP of approximately ₹21.50 per share. Against the upper IPO price of ₹151, this indicates an unofficial estimated listing price of approximately ₹172.50 per share, representing an indicative premium of around 14.24%.

At a GMP of ₹21.50, the indicative premium for one retail lot of 99 shares would be approximately ₹2,128.50. However, GMP is unofficial and should not be treated as a guaranteed listing gain or listing price.

Check the latest Zetwerk Manufacturing Businesses IPO GMP, Kostak Rate and Subject to Sauda information before making an investment decision.

Zetwerk Manufacturing Businesses IPO Subscription Status

The Zetwerk Manufacturing Businesses IPO opened for subscription on 15-October-2026. Initial reports indicated relatively subdued bidding on the opening day, with the issue receiving approximately 12% subscription at the time of reporting.

Subscription figures can change significantly during the three-day bidding period. Investors should check the latest category-wise subscription data before making an application decision.

Zetwerk Manufacturing Businesses IPO Review

The Zetwerk Manufacturing Businesses IPO provides investors exposure to a diversified manufacturing platform with operations spanning energy products, precision products, capital goods and industrial commodities.

The company has built a large manufacturing ecosystem combining its own manufacturing facilities with thousands of third-party suppliers. Its exposure to renewable energy, electronics, EVs, aerospace, defence and AI infrastructure provides opportunities for long-term growth.

However, the company’s financial profile remains a key concern. Despite strong revenue growth, Zetwerk reported a substantial loss of ₹1,606.17 Crores in FY2026 and has experienced negative operating cash flows. Borrowings have also increased significantly.

The IPO valuation should therefore be evaluated primarily on the company’s revenue growth, manufacturing scale, order book, operating leverage and future path to profitability rather than traditional P/E-based valuation metrics.

For investors with a high-risk appetite, Zetwerk may offer exposure to India’s growing manufacturing and industrial ecosystem. However, investors should carefully evaluate the company’s continuing losses, cash-flow position, debt levels and ability to achieve sustainable profitability before applying.

Zetwerk Manufacturing Businesses IPO Prospectus

The Zetwerk Manufacturing Businesses IPO Prospectus contains detailed information about the company’s business, financial performance, risk factors, promoters, management, selling shareholders, IPO objectives and proposed use of funds. Investors should read the RHP carefully before applying for the issue.

Zetwerk Manufacturing Businesses IPO Allotment Date & Details

After the IPO closes, the registrar will process the basis of allotment. Investors can check their application status through the registrar’s website once the allotment process is completed.

Zetwerk Manufacturing Businesses IPO Registrar

KFin Technologies Limited is the registrar for the Zetwerk Manufacturing Businesses IPO. The registrar is responsible for processing IPO applications, maintaining application records and handling the allotment process.

Website: www.kfintech.com

Zetwerk Manufacturing Businesses IPO Contact Address

Zetwerk Manufacturing Businesses Limited

Registered Office: #84/1, Ground & 1st Floor, Green Glen Layout, Bellandur, Bengaluru, Karnataka, India.

Email: cs@zetwerk.com

Website: www.zetwerk.com

Zetwerk Manufacturing Businesses IPO Lead Managers

The book running lead managers to the Zetwerk Manufacturing Businesses IPO include:

• Kotak Mahindra Capital Company Limited
• Morgan Stanley India Company Private Limited
• Goldman Sachs (India) Securities Private Limited
• Avendus Capital Private Limited
• JM Financial Limited
• HSBC Securities and Capital Markets (India) Private Limited
• Pantomath Capital Advisors Private Limited

Zetwerk Manufacturing Businesses IPO FAQs

When is the Zetwerk Manufacturing Businesses IPO opening date?

The Zetwerk Manufacturing Businesses IPO opened for subscription on 15-October-2026 and will close on 19-October-2026.

What is the Zetwerk Manufacturing Businesses IPO price band?

The Zetwerk Manufacturing Businesses IPO price band is ₹143 to ₹151 per share.

What is the minimum lot size of the Zetwerk IPO?

The minimum application lot is 99 shares, requiring ₹14,949 at the upper price band of ₹151 per share.

What is the Zetwerk Manufacturing Businesses IPO size?

The Zetwerk IPO size is approximately ₹5,012.33 Crores, consisting of a fresh issue of approximately ₹2,830 Crores and an offer for sale of approximately ₹2,182.33 Crores.

How will Zetwerk use the IPO proceeds?

The company plans to use a significant portion of the fresh issue proceeds for repayment or prepayment of borrowings and for funding inorganic growth and strategic acquisitions.

What is the latest Zetwerk IPO GMP?

As of 15-October-2026, the reported GMP was approximately ₹21.50 per share. Against the upper issue price of ₹151, this indicates an unofficial estimated listing price of approximately ₹172.50. GMP is unofficial and can change before listing.

What is the latest Zetwerk IPO subscription status?

Initial reports on 15-October-2026 indicated approximately 12% subscription for the Zetwerk IPO at the time of reporting. Subscription figures can change throughout the bidding period.

Is Zetwerk Manufacturing Businesses profitable?

No. Zetwerk reported a restated loss after tax of approximately ₹1,606.17 Crores in FY2026. The company also reported losses in FY2024 and FY2025.

What are the main businesses of Zetwerk?

Zetwerk operates through two major business segments: the Manufacturing Business, comprising Energy Products, Precision Products and Capital Goods, and the Ecosystem Business, operated under the Terra91 brand.

How many manufacturing facilities does Zetwerk have?

As of 31-March-2026, Zetwerk had 26 own manufacturing facilities across India, Spain, Germany and the United States, supported by approximately 6,979 third-party suppliers across 26 countries.

When is the Zetwerk IPO allotment date?

The tentative basis of allotment date is 21-October-2026.

When will Zetwerk IPO shares be listed?

The Zetwerk Manufacturing Businesses shares are expected to be listed on the NSE and BSE on 23-October-2026.

Where can I check Zetwerk IPO allotment status?

Investors can check the Zetwerk IPO allotment status through the official website of KFin Technologies Limited, the registrar to the issue, after the basis of allotment is finalized.

Is Zetwerk IPO GMP reliable?

No. IPO GMP is an unofficial market indicator and can change frequently. Investors should not consider GMP as a guaranteed indication of the actual listing price or listing gain.

The post Zetwerk Manufacturing Business IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

The Tonbo Imaging India IPO opened for subscription on 15-October-2026 and will close on 19-October-2026. The IPO is entirely an Offer for Sale (OFS) of 1,21,74,046 equity shares. There is no fresh issue, meaning the company will not receive any proceeds from the IPO. Investors can use this page to check the Tonbo Imaging India IPO date, price band, market lot, IPO size, GMP, allotment date, subscription details and listing information.

Tonbo Imaging India serves defence and security organisations across international markets. The company states that its systems are deployed across 24 countries, with more than 28,000 units installed in the field. Its product development is based on internally owned intellectual property, and the company focuses on advanced imaging, surveillance, targeting, communication and guidance technologies.

Tonbo Imaging India IPO Promoters

Ankit Kumar, Arvind Kondangi Lakshmikumar and Cecilia D’Souza are the promoters of Tonbo Imaging India Limited. The promoters have been associated with the development and growth of the company’s defence electronics business.

Tonbo Imaging India Business Overview

Tonbo Imaging India Limited is a defence electronics original equipment manufacturer (OEM) engaged in the design, development and manufacturing of advanced electro-optic and infrared technologies.

The company’s product portfolio covers several defence applications, including thermal imaging systems, weapon sights, missile seekers, fire control systems, missile guidance systems, targeting systems, surveillance systems and handheld thermal imaging devices.

Tonbo Imaging operates across tactical, platform and surveillance-related defence applications. The company also has international exposure and supplies its products to defence and security organisations across multiple countries.

As of 30-June-2026, Tonbo Imaging India had 339 permanent employees working across product design and development, manufacturing, project management, sales, finance, human resources and management functions.

Tonbo Imaging India IPO Date, Details & Price Band

The Tonbo Imaging India IPO price band, IPO dates, issue size, face value and other important details are provided in the table below.

Tonbo Imaging India IPO Market Lot

The Tonbo Imaging India IPO minimum market lot is 21 shares. Based on the upper price band of ₹700 per share, one retail lot requires an application amount of ₹14,700. Investors can bid for shares in multiples of 21.

Tonbo Imaging India IPO: Objects of the Issue

The Tonbo Imaging India IPO is entirely an Offer for Sale (OFS). The issue consists of 1,21,74,046 equity shares being offered by existing shareholders.

Since there is no fresh issue of shares, Tonbo Imaging India Limited will not receive any proceeds from the IPO. The proceeds from the offer, after applicable offer expenses, will accrue to the selling shareholders.

Tonbo Imaging India Financial Performance

Tonbo Imaging India reported revenue of ₹431.90 crore in FY2024, which increased to ₹474.39 crore in FY2025 before declining to ₹369.94 crore in FY2026. Profit after tax stood at ₹68.54 crore in FY2024, ₹72.76 crore in FY2025 and ₹50.88 crore in FY2026.

The company also reported a loss of ₹17.74 crore for the quarter ended 30-June-2026. Investors should therefore consider the latest quarterly performance along with the full-year financial results when evaluating the IPO.

Tonbo Imaging India IPO Strengths

Tonbo Imaging India operates in a specialised defence electronics segment and has developed capabilities across electro-optics, infrared imaging, surveillance, targeting and guidance systems.

• Defence electronics expertise: The company focuses on advanced defence and security electronics and related imaging technologies.
• Specialised product portfolio: Its products include thermal imaging systems, weapon sights, missile seekers, fire control systems, guidance systems and targeting solutions.
• International presence: The company serves defence and security organisations across 24 countries and has more than 28,000 systems deployed in the field.
• Proprietary technology: Tonbo develops products using internally owned intellectual property.
• Defence sector opportunity: Increasing focus on indigenous defence manufacturing and modernisation may provide opportunities for specialised Indian defence electronics companies.
• Established profitability: The company reported PAT of ₹50.88 crore in FY2026 despite a decline in revenue from the previous year.

Tonbo Imaging India IPO Risks

Investors should carefully evaluate the risks disclosed in the company’s RHP before applying for the IPO. Defence electronics businesses can be affected by government procurement cycles, project delays, customer concentration, regulatory requirements and changes in defence spending.

The company’s financial performance has also shown volatility. Revenue declined from ₹474.39 crore in FY2025 to ₹369.94 crore in FY2026, while PAT declined from ₹72.76 crore to ₹50.88 crore during the same period.

The company also reported a loss of ₹17.74 crore for the quarter ended 30-June-2026. Investors should therefore consider whether the recent quarterly weakness is temporary or indicative of a broader change in operating performance.

Other risks may include dependence on defence procurement programmes, lengthy sales cycles, project execution risks, technology development requirements, competition, international market conditions and supply-chain dependencies.

Tonbo Imaging India IPO GMP & Grey Market Premium

The Tonbo Imaging India IPO GMP (Grey Market Premium) represents the premium at which the IPO is reportedly being traded in the unofficial grey market. GMP can change frequently depending on IPO demand, subscription levels, market sentiment and broader market conditions.

As of 15-October-2026, reports were indicating a GMP of approximately ₹500 per share against the upper IPO price of ₹700. This implies an indicative grey-market listing price of around ₹1,200 per share, or approximately 71.43% above the upper price band.

At a GMP of ₹500, the indicative premium for one lot of 21 shares would be approximately ₹10,500. However, GMP is unofficial and should not be treated as a guaranteed listing gain or listing price.

Check the latest Tonbo Imaging India IPO GMP, Kostak Rate and Subject to Sauda information before making an investment decision.

Tonbo Imaging India IPO Subscription Status

The Tonbo Imaging India IPO opened for subscription on 15-October-2026. According to subscription data reported on 15-October-2026 at around 12:21 PM, the issue was subscribed approximately 1.20 times overall.

Subscription figures can change throughout the bidding period. Investors should check the latest category-wise subscription data before making an application decision.

Tonbo Imaging India IPO Review

The Tonbo Imaging India IPO provides exposure to the specialised defence electronics industry, with the company focusing on electro-optics, infrared imaging, surveillance, targeting, communication and guidance systems.

The company has an international customer base and a specialised technology portfolio. Its presence in defence electronics may benefit from increased demand for indigenous defence systems and India’s focus on domestic defence manufacturing.

However, investors should also consider the company’s declining FY2026 revenue and profit, the ₹17.74 crore loss reported for the quarter ended June 2026, and the valuation implied by the upper IPO price.

The IPO is also entirely an OFS. Therefore, the company will not receive new capital from the IPO for business expansion, debt repayment or other corporate purposes.

The final IPO decision should be based on the company’s financial performance, valuation, business outlook, competitive position, defence-sector opportunities, risk factors and prevailing market conditions rather than GMP alone.

Tonbo Imaging India IPO Prospectus

The Tonbo Imaging India IPO Prospectus contains detailed information about the company’s business, financial performance, risk factors, promoters, management, legal matters, selling shareholders and the proposed IPO. Investors should read the RHP carefully before applying for the issue.

Tonbo Imaging India IPO Allotment Date & Details

After the IPO closes, the registrar will process the basis of allotment. Investors can check their application status through the registrar’s website once the allotment process is completed.

Tonbo Imaging India IPO Registrar

KFin Technologies Limited is the registrar for the Tonbo Imaging India IPO. The registrar is responsible for processing IPO applications, maintaining application records and handling the allotment process.

Tel: +91 40 6716 2222 / 1800 309 4001

E-mail: tonbo.ipo@kfintech.com

Website: www.kfintech.com

Investor Grievance E-mail: einward.ris@kfintech.com

Contact Person: Williams R

SEBI Registration Number: INR000000221

Tonbo Imaging India IPO Contact Address

Tonbo Imaging India Limited

Address: No.3 Chikkayellappa Tower-II, 1st C Main, Sarjapur Main Road, Jakkasandra Extension, Chikkayellappa Industrial Layout, Bengaluru, Karnataka, 560034

Phone: +91 80 41 999 555

Email: compliance@tonboimaging.com

Tonbo Imaging India IPO Lead Managers

JM Financial Limited

7th Floor, Cnergy,
Appasaheb Marathe Marg,
Prabhadevi,
Mumbai 400 025,
Maharashtra, India

Tel: +91 22 6630 3030

E-mail: tonbo.ipo@jmfl.com

Investor Grievance E-mail: grievance.ibd@jmfl.com

Website: www.jmfl.com

Contact Person: Prachee Dhuri

SEBI Registration No.: INM000010361

IIFL Capital Services Limited (formerly known as IIFL Securities Limited)

24th Floor, One Lodha Place,
Senapati Bapat Marg,
Lower Parel (West),
Mumbai 400 013,
Maharashtra, India

Tel: +91 22 4646 4728

E-mail: tonbo.ipo@iiflcap.com

Investor Grievance E-mail: ig.ib@iiflcapital.com

Website: www.iiflcapital.com

Contact Person: Gaurav Mittal / Pawan Kumar Jain

SEBI Registration No.: INM000010940

Tonbo Imaging India IPO FAQs

When is the Tonbo Imaging India IPO opening date?

The Tonbo Imaging India IPO opened for subscription on 15-October-2026 and will close on 19-October-2026.

What is the Tonbo Imaging India IPO price band?

The Tonbo Imaging India IPO price band is ₹665 to ₹700 per share.

What is the minimum lot size of the Tonbo Imaging India IPO?

The minimum application lot is 21 shares, requiring ₹14,700 at the upper price band of ₹700 per share.

What is the Tonbo Imaging India IPO size?

The Tonbo Imaging India IPO size is approximately ₹852.18 crore. The issue consists entirely of an Offer for Sale (OFS) of 1,21,74,046 equity shares, with no fresh issue.

Is Tonbo Imaging India IPO a fresh issue or OFS?

The Tonbo Imaging India IPO is a 100% Offer for Sale (OFS). The company is not issuing any new shares and therefore will not receive proceeds from the IPO.

What is the latest Tonbo Imaging India IPO GMP?

As of 15-October-2026, the reported GMP was around ₹500 per share. Against the upper issue price of ₹700, this indicates an unofficial estimated listing price of approximately ₹1,200. GMP is unofficial and can change before listing.

What is the latest Tonbo Imaging India IPO subscription status?

As of approximately 12:21 PM on 15-October-2026, the issue was reported to be subscribed around 1.20 times overall. NII subscription stood at 2.21x and retail subscription at 1.46x at that time.

What is the Tonbo Imaging India IPO allotment date?

The basis of allotment is scheduled for 21-October-2026.

When will Tonbo Imaging India IPO be listed?

The Tonbo Imaging India shares are scheduled to be listed on the NSE and BSE on 23-October-2026.

Where can I check Tonbo Imaging India IPO allotment status?

Investors can check the Tonbo Imaging India IPO allotment status through the official website of KFin Technologies Limited, the registrar to the issue, after the basis of allotment is finalized.

Is Tonbo Imaging India IPO GMP reliable?

No. IPO GMP is an unofficial market indicator and can change frequently. Investors should not consider GMP as a guaranteed indication of the actual listing price or listing gain.

The post Tonbo Imaging India IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

The Fusion CX IPO opened on 14-October-2026 and is scheduled to close on16-October-2026. The IPO consists of a fresh issue as well as an offer for sale by existing shareholders. Investors can use this page to check the Fusion CX IPO date, price band, market lot, IPO size, GMP, allotment date, subscription details and listing information.

Fusion CX serves clients across several industries, including telecommunications and utilities, healthcare and life sciences, banking, financial services and insurance (BFSI), and retail. The company has developed domain expertise across these sectors and combines customer support operations with technology-enabled business solutions.

Fusion CX IPO Promoters

Pankaj Dhanuka, Kishore Saraogi, P N S Business Pvt. Ltd. and Rasish Consultants Pvt. Ltd. are the promoters of Fusion CX. The promoters and promoter group have played an important role in developing the company’s customer experience and business process services operations.

Fusion CX Business Overview

Fusion CX operates in the customer experience and business process services industry. The company helps businesses manage customer interactions through several digital and traditional channels, including voice, email, chat, social media and messaging.

Its service portfolio is supported by technology and includes solutions designed to improve customer engagement, operational efficiency and service delivery. In addition to its customer experience business, Fusion CX provides AI data infrastructure services covering activities such as data collection, data annotation and labelling and teleoperations.

The company focuses on several industry verticals, including telecom and utilities, healthcare and life sciences, BFSI and retail. Its sector-focused approach allows it to develop specialized business process solutions for different customer requirements.

Fusion CX IPO Date, Details & Price Band

The Fusion CX IPO price band, IPO dates, issue size, face value and other important details are provided in the table below.

Fusion CX IPO Market Lot

The Fusion CX IPO minimum market lot is 51 shares. Based on the upper price band of ₹289 per share, one retail lot requires an application amount of ₹14,739.

Investors should note that the amount blocked for an IPO application depends on the number of lots applied for and the applicable IPO price band.

Fusion CX IPO: Objects of the Issue

The fresh issue component of the Fusion CX IPO is intended to support the company’s business and corporate requirements. Investors should refer to the final Red Herring Prospectus (RHP) for the precise allocation of funds and the company’s stated objectives of the issue.

The offer for sale component represents shares offered by existing shareholders. The proceeds from an offer for sale generally accrue to the selling shareholders rather than to the company.

Fusion CX Financial Performance

Fusion CX has reported growth in revenue and profitability across the financial years presented in its IPO information. Revenue increased from ₹1,021.53 crore in FY2024 to ₹1,352.03 crore in FY2025 and further to ₹1,851.83 crore in FY2026.

Profit after tax also increased during the same period, rising from ₹36.26 crore in FY2024 to ₹74.31 crore in FY2025 and ₹169.84 crore in FY2026. This indicates a significant improvement in the company’s reported profitability over the period.

Fusion CX IPO Strengths

Fusion CX has several business characteristics that may be relevant to investors evaluating the IPO. The company operates across multiple customer experience channels and serves clients from different industry verticals.

• Diversified customer experience services: The company provides services through voice, email, chat, social media and messaging channels.
• Technology-enabled operations: Technology plays an important role in its service delivery model, including AI data infrastructure services.
• Multiple industry verticals: The company serves sectors such as telecom, utilities, healthcare, life sciences, BFSI and retail.
• AI data infrastructure exposure: Its services include data collection, data annotation, data labelling and teleoperations.
• Revenue and profit growth: The financial information supplied for the IPO shows growth in both revenue and profit after tax over the reported period.

Fusion CX IPO Risks

Investors should also evaluate the risks disclosed in the company’s RHP before applying for the IPO. The customer experience and business process services industry is competitive and can be affected by changing technology, customer requirements and pricing pressure.

The increasing adoption of automation and artificial intelligence may create opportunities for the company, but it can also change the competitive landscape. Investors should therefore evaluate Fusion CX’s ability to maintain customer relationships, expand its service portfolio and adapt to technological changes.

Other risks may include dependence on customers and specific industry verticals, employee-related costs, competition, changes in international markets and other factors identified in the company’s RHP.

Fusion CX IPO GMP & Grey Market Premium

The Fusion CX IPO GMP (Grey Market Premium) represents the premium at which the IPO is reportedly being traded in the unofficial grey market. GMP can change frequently depending on IPO demand, subscription levels, market sentiment and broader market conditions.

Investors should remember that the grey market is unofficial and the GMP should not be treated as a guaranteed indicator of the Fusion CX IPO listing price.

Check the latest Fusion CX IPO GMP, Kostak Rate and Subject to Sauda information before making an investment decision.

Fusion CX IPO Review

The Fusion CX IPO offers investors exposure to the customer experience and business process services industry along with technology-enabled and AI data infrastructure services. The company’s presence across multiple industry verticals and communication channels provides diversification within its business operations.

From the financial information provided, the company has shown strong growth in revenue and profit after tax in the reported financial years. However, investors should compare the IPO valuation with the company’s earnings, growth rate, industry peers and the risks disclosed in the RHP.

The final IPO decision should be based on the company’s financial performance, valuation, business outlook, IPO objectives, competitive position, risk factors and prevailing market conditions rather than GMP alone.

Fusion CX IPO Prospectus

The Fusion CX IPO Prospectus contains detailed information about the company’s business, financial performance, risk factors, promoters, management, legal matters and the proposed IPO. Investors should read the RHP carefully before applying for the issue.

Fusion CX IPO Allotment Date & Details

After the IPO closes, the registrar will process the basis of allotment. Investors can check their application status using the registrar’s website once the allotment process is completed.

Fusion CX IPO Registrar

KFin Technologies Limited is the registrar for the Fusion CX IPO. The registrar is responsible for processing IPO applications, maintaining application records and handling the allotment process.

301, The Centrium, 3rd Floor,
57, Lal Bahadur Shastri Road,
Nav Pada, Kurla (West),
Kurla, Mumbai,
Maharashtra, India 400 070

Tel: +91 40 67162222 / 18003094001
E-mail: fusion.ipo@kfintech.com
Website: www.kfintech.com
Investor Grievance ID: einward.ris@kfintech.com
Contact Person: Williams R
SEBI Registration Number: INR000000221

Fusion CX IPO Contact Address

Fusion CX Ltd
Address: Plot No. Y9, Block EP & GP,
Sector-5, Bidhan Nagar,
Salt Lake,
Kolkata, West Bengal, 700091

Phone: 033 4508 6520
Email: secretarial@fusioncx.com

Fusion CX IPO Lead Managers

Motilal Oswal Investment Advisors Limited

Motilal Oswal Tower
Rahimtullah Sayani Road
Opposite Parel ST Depot
Prabhadevi, Mumbai 400 025
Maharashtra, India

Tel: +91 22 7193 4380
E-mail: fusion.ipo@motilaloswal.com
Investor Grievance E-mail: moiaplredressal@motilaloswal.com
Website: www.motilaloswal.com
Contact Person: Vaibhav Shah
SEBI Registration No.: INM000011005

IIFL Capital Services Limited (formerly known as IIFL Securities Limited)

24th Floor, One Lodha Place,
Senapati Bapat Marg,
Lower Parel (West),
Mumbai 400013,
Maharashtra, India

Tel: +91 22 4646 4728
E-mail: fusioncx.ipo@iiflcap.com
Investor Grievance E-mail: ig.ib@iiflcapital.com
Website: www.iiflcapital.com
Contact Person: Dhruv Bhavsar / Pawan Kumar Jain
SEBI Registration No.: INM000010940

Nuvama Wealth Management Limited

801–804, Wing A, Building No. 3,
Inspire BKC, G Block, Bandra Kurla Complex East,
Mumbai 400 051,
Maharashtra, India

Tel: +91 22 4009 4400
E-mail: fusion@nuvama.com
Investor Grievance E-mail: customerservice.mb@nuvama.com
Website: www.nuvama.com
Contact Person: Lokesh Shah
SEBI Registration Number: INM000013004

Fusion CX IPO FAQs

When is the Fusion CX IPO opening date?

The Fusion CX IPO is scheduled to open on 14-October-2026.

What is the Fusion CX IPO price band?

The supplied IPO information mentions a price band of ₹275 to ₹289 per share.

What is the minimum lot size of the Fusion CX IPO?

The minimum application lot is 51 shares, requiring ₹14,739 at the upper price band of ₹289 per share.

What is the Fusion CX IPO size?

The supplied issue structure contains a fresh issue of ₹500 crore and an offer for sale of ₹202 crore, making a calculated total issue size of ₹702 crore. Please verify this against the final RHP before publishing.

Where can I check the Fusion CX IPO allotment status?

Investors can check the Fusion CX IPO allotment status through the IPO registrar’s official website after the basis of allotment is finalized.

Is Fusion CX IPO GMP reliable?

No. IPO GMP is an unofficial market indicator and can change frequently. Investors should not consider GMP as a guaranteed indication of the actual listing price.

The post Fusion CX IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

The Vaibhav Vyapaar IPO

Vaibhav Vyapaar has set its IPO price at Rs 54 per share. They divided the IPO into three general categories: 1) QIB, 2) Retail, and 3) NII.

Vaibhav Vyapaar is a Non-Banking Financial Company (NBFC) registered with the Reserve Bank of India (RBI).

They provide unsecured personal loans to salaried individuals and self-employed individuals through our fully digital lending platform, both on a direct lending and co-lending basis. In parallel, we also generate revenue by offering our application and technology services to other NBFCs.

Their operating model enables credit access, particularly first-time borrowers, including lower-income salaried professionals.

They offers personal loans under the brand “LoanFront”, through Mobile application namely “LoanFront- Personal Loan App” which provides credit facilities to retail customers. Alongside our direct lending portfolio, we also participate in colending arrangements other NBFCs, wherein loans are originated, underwriting process along with documentation, and services.

Check:- Upcoming SME IPO 2026

Vaibhav Vyapaar IPO Promoter Holding

Itha Venkata Raghava Gowrinath and CapFront Technologies Pvt.Ltd is the promoter of the company.

Vaibhav Vyapaar IPO Date, Details & Price Band

Vaibhav Vyapaar IPO Market Lot

The minimum market lot for the Vaibhav Vyapaar IPO is 4000 shares, with an amount of ₹2,16,000 per application.

Vaibhav Vyapaar IPO: Object of the Issue

1. Augment the capital base of the company
2. General Corporate Purpose

Restated Financial Information (Amt. in Crore)

Vaibhav Vyapaar IPO GMP Grey Market Premium

Vaibhav Vyapaar IPO GMP (Grey Market Premium) has started today. Check the Latest Vaibhav Vyapaar IPO GMP Grey Market Premium, Kostak Rates, and Subject to Sauda Price here.

Vaibhav Vyapaar IPO Prospectus

Vaibhav Vyapaar IPO Form Download

Vaibhav Vyapaar IPO is available on the BSE Website as well as on our Portal. Please click here, Vaibhav Vyapaar IPO Form Download.

Vaibhav Vyapaar IPO Allotment Date & Details

Registrar of Vaibhav Vyapaar IPO

KFIN TECHNOLOGIES LIMITED
SEBI Registration Number: INR000000221
Address: 301, The Centrium, 3rd Floor, 57, Lal Bahadur Shastri Road, Nav Pada, Kurla
(West), Kurla, Mumbai, Maharashtra, India, 400070
Tel. Number: +91-40-67162222/18003094001
Email Id: vaibhav.ipo@kfintech.com
Investors Grievance Id: einward.ris@kfintech.com
Website: https://www.kfintech.com/
Contact Person: Williams R
CIN: L72400MH2017PLC444072

Vaibhav Vyapaar Contact Details

Vaibhav Vyapaar Ltd
Arch Square-X2, Unit-1406
14th Floor, EP-GP Block, Sector V, Bidhannagar
Bidhan Nagar CK Market, North 24 Parganas, Saltlak
Kolkata, West Bengal, 700091
9986611345
investors@vaibhavvyapaar.com

Vaibhav Vyapaar IPO Lead Managers

GETFIVE ADVISORS PRIVATE LIMITED
SEBI Registration Number: INM000013147
Address: 4th Floor, Motilal Oswal Tower, Opp. Zion Z1 Tower, Sindhubhavan Road, Thaltej, Ahmedabad,
Gujarat – 380059
Telephone Number: +91 79907 29901
Email Id: investor.grievance@getfive.in
Investors Grievance Id: investor.grievance@getfive.in
Website: www.getfive.in
Contact Person: Aman Jain
CIN: U70200GJ2023PTC144770

The post Vaibhav Vyapaar IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

There are three basic categories in HD Fire Protect IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail.

HD Fire Protect are an Indian manufacturer and supplier of fire protection equipment and systems, offering a comprehensive portfolio spanning water, foam, and gas-based fire suppression systems, which are also generally known as fire fighting products.

They develop majority of their products in-house with proprietary designs to meet national and international standards, serving highhazard industrial applications as well as residential and commercial sectors.

They were the second-largest manufacturer of fire protection equipment and systems in India in terms of operating income (revenue from operations) in Fiscal 2025 and the largest exporter by value (equipment) in Fiscal 2025.

They have export sales in 49 countries as of the three months period ended June 30, 2026 and more than 90 countries as of Fiscal 2026.

They offerings are spread across 8 product categories, namely – (a) sprinklers, alarm valves and accessories, (b) deluge valves, deluge skids and pre-action systems, (c) foam equipment and suppression systems, (d) monitors and monitor nozzles, (e) systems valves and accessories, (f) water spray nozzles, (g) custom engineered systems, and (h) gas suppression systems, covering a wide spectrum of (a) industrial end use in sectors such as industrials, heavy engineering, aerospace, oil & gas, refining and petrochemicals, power & energy, pharmaceuticals, data centres, warehousing amongst others; and (b) residential and commercial end use in sectors such as hospitality, healthcare, retail, education, banking and warehousing.

HD Fire Protect IPO Promoters

Harish Narshi Dharamshi, Kusum Harish Dharamshi, Miheer Sadanand Ghotikar, Parika Miheer Ghotikar and Anik Narendra Dharamshi are the promoters of the company.

HD Fire Protect IPO Date, Details & Price Band

The HD Fire Protect IPO Price Band, IPO Dates, Market lot and other details are mentioned in the table below.

HD Fire Protect IPO Market Lot

The HD Fire Protect IPO minimum market lot is 55 shares, with a ₹15,000 application amount.

Restated Consolidated Financial Information (Amt. in Crore)

HD Fire Protect IPO GMP & Grey Market Premium

The HD Fire Protect IPO GMP (Grey Market Premium) has started today. Check the Latest HD Fire Protect IPO GMP, Kostak Rates, and Subject to Sauda Price here.

HD Fire Protect IPO Prospectus

The HD Fire Protect IPO Prospectus is Available on the HD Fire Protect/BSE and SEBI websites, as well as on our Portal. Please click here to download the HD Fire Protect IPO Prospectus.

HD Fire Protect IPO Allotment Date & Details

HD Fire Protect IPO Registrar

MUFG Intime India Private Limited
(Formerly Link Intime India Private
Limited)
C-101, Embassy 247,
LBS Marg, Vikhroli (West)
Mumbai 400 083
Maharashtra, India
Tel: +91 81081 14949
E-mail: hdfire.ipo@in.mpms.mufg.com
Website: www.in.mpms.mufg.com
Investor grievance e-mail:
hdfire.ipo@in.mpms.mufg.com
Contact person: Shanti Gopalkrishnan
SEBI registration no.: INR000004058

HD Fire Protect IPO Contact Address

HD Fire Protect Ltd
Address : O-611
6th Floor, Runwal R Square
Opp. Veena Nagar, L. B. S. Marg, Mulund West
Mumbai, Maharashtra, 400080
+91 22 35287000
investors@hdfire.com

HD Fire Protect IPO Lead Managers

IIFL Capital Services Limited
(formerly IIFL Securities Limited)
24th Floor, One Lodha Place,
Senapati Bapat Marg, Lower Parel (W).
Mumbai – 400 013, India
Telephone: +91 (22) 4646 4728
Email: hdfire.ipo@iiflcap.com
Website: www.iiflcapital.com
Investor grievance E-mail: ig.ib@iiflcap.com
Contact person: Vikranth Settipalli / Pawan Kumar Jain
SEBI registration no.: INM000010940

Anand Rathi Advisors Limited
11th floor, Times Tower,
Kamala City, Senapati Bapat Marg,
Lower Parel West, Mumbai – 400013,
Maharashtra, India
Telephone: +91 (22) 4047 7000
Email: hdfpl.ipo@rathi.com
Website: www.anandrathiib.com
Investor grievance E-mail: grievance.ecm@rathi.com
Contact person: Shivani Tapadia / Suhani Bafna
SEBI registration no.: INM000010478

Ambit Private Limited
Ambit House,
449, Senapati Bapat Marg,
Lower Parel,
Mumbai – 400013
Maharashtra, India
Telephone: +91 (22) 6623 3030
Email: hdfire.ipo@ambit.co
Website: www.ambit.co
Investor grievance E-mail: customerservicemb@ambit.co
Contact person: Anmol Modi/ Nitya Chandak
SEBI registration no.: INM000010585

The post HD Fire Protect IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

There are three basic categories in Jio Platforms IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail Individual Investors.

Jio Platforms Limited is a technology and digital connectivity platform built around proprietary digital technology and pan-India digital connectivity. Through its material subsidiary, Reliance Jio Infocomm Limited (“RJIL”), the company provides mobile connectivity, broadband, digital services, enterprise connectivity, cloud, AI and other technology-enabled services.

Jio Platforms’ digital connectivity forms a fundamental pillar of India’s growing digital economy. The company has built a large integrated digital ecosystem combining connectivity, digital applications, entertainment, cloud and enterprise services.

Its material subsidiary, Reliance Jio Infocomm Limited (“RJIL”), served 524.4 million customers in India as of March 31, 2026. Jio also carried approximately 60% of India’s wireless data traffic in Fiscal 2026.

Jio Platforms IPO Promoters

Reliance Industries Limited is the promoter of Jio Platforms Limited. Reliance Industries held approximately 66.43% of Jio Platforms before the IPO.

Jio Platforms IPO Date, Details & Price Band

The Jio Platforms IPO Price Band, IPO Dates, Market Lot and other details are mentioned in the table below.

The IPO is structured as a fresh issue, meaning the proceeds will go to Jio Platforms rather than to existing selling shareholders. Eligible Reliance Industries shareholders have a reserved portion of up to ₹2,500 Crores, while eligible employees have a reservation of up to ₹500 Crores.

Jio Platforms IPO Market Lot

The Jio Platforms IPO minimum market lot is 12 shares, requiring an application amount of ₹13,428 at the upper price band of ₹1,119 per share.

Eligible employees will receive a discount of ₹54 per share. Eligible Reliance Industries shareholders can participate through the separate shareholder reservation, subject to the applicable eligibility and record-date requirements.

Jio Platforms IPO Business Overview

Jio Platforms Limited is the holding company for Reliance’s digital services ecosystem. Its principal operating subsidiary, Reliance Jio Infocomm Limited (RJIL), operates India’s large-scale mobile and digital connectivity network.

Jio’s business extends beyond mobile connectivity and includes 5G services, fixed broadband, JioFiber, AirFiber, enterprise connectivity, cloud services, digital applications, entertainment, AI-enabled services and other digital products.

As of March 31, 2026, RJIL had 524.4 million customers. Jio’s network carried approximately 60% of India’s wireless data traffic during Fiscal 2026. The company’s average revenue per user (ARPU) was approximately ₹214 for the March 2026 quarter.

Jio Platforms IPO Objects of the Issue

The primary objective of the Jio Platforms IPO is to strengthen the company’s balance sheet through repayment or prepayment of borrowings of its material subsidiary, Reliance Jio Infocomm Limited.

• ₹27,500 Crores: Prepayment, in full or in part, of certain outstanding borrowings availed by Reliance Jio Infocomm Limited.
• General Corporate Purposes: The remaining proceeds will be used for general corporate purposes, subject to the limits and conditions specified in the offer document.

Since the IPO is entirely a fresh issue, the proceeds will be received by Jio Platforms and will not be paid to existing shareholders as an OFS.

Restated Consolidated Financial Information (Amt. in Crore)

Jio Platforms reported strong financial growth in FY2026. Total income increased to ₹1,49,759.10 Crores, while profit after tax increased to ₹30,052.70 Crores. EBITDA increased to approximately ₹76,255.40 Crores, with an EBITDA margin of approximately 50.92% on total income.

Jio Platforms IPO Latest Quarterly Financial Performance

For the quarter ended 30-June-2026, Jio Platforms reported total income of approximately ₹40,197.90 Crores, EBITDA of approximately ₹20,864.50 Crores and profit after tax of approximately ₹7,764.10 Crores.

Jio Platforms IPO Strengths

• Massive customer base: RJIL served 524.4 million customers as of March 31, 2026.
• Strong market position: Jio carried approximately 60% of India’s wireless data traffic in Fiscal 2026.
• Strong financial growth: Total income, EBITDA and PAT have increased consistently over the last three financial years.
• High EBITDA margin: Jio Platforms reported an EBITDA of approximately ₹76,255.40 Crores in FY2026.
• Large digital ecosystem: The company operates across connectivity, broadband, enterprise services, cloud, entertainment, digital applications and AI-enabled services.
• 5G leadership: Jio has developed a nationwide 5G network and continues to expand 5G adoption across its customer base.
• Strong parentage: Jio Platforms is promoted by Reliance Industries Limited, one of India’s largest diversified business groups.
• Technology and AI opportunity: The company is expanding beyond connectivity into cloud, AI, digital services and other higher-value technology businesses.

Jio Platforms IPO Risks

• Dependence on RJIL: A substantial portion of Jio Platforms’ business and financial performance is dependent on its material subsidiary, Reliance Jio Infocomm Limited.
• High promoter dependence: Reliance Industries Limited is the promoter and holds a significant stake in Jio Platforms even after the IPO.
• Customer churn risk: The telecom business is highly dependent on customer retention, additions and the ability to maintain competitive tariffs.
• Tariff and regulatory risk: Changes in telecom regulations, spectrum requirements, pricing policies and government regulations may affect profitability.
• High capital expenditure: Telecom networks, 5G infrastructure, broadband, cloud and data-centre expansion require substantial capital investment.
• Competition: Jio competes with established telecom operators including Bharti Airtel and Vodafone Idea across different segments.
• Reliance group concentration: Certain business relationships within the Reliance group create dependence on related parties and group entities.
• Technology risk: Rapid technological changes in telecommunications, cloud computing, AI and digital services require continuous investment and innovation.

Jio Platforms IPO GMP & Grey Market Premium

The Jio Platforms IPO GMP (Grey Market Premium) represents the premium at which the IPO shares are reportedly being traded in the unofficial grey market before listing.

As of 15-October-2026, the latest reported GMP was approximately ₹212 per share. Against the upper IPO price of ₹1,119, this indicates an unofficial estimated listing price of approximately ₹1,331 per share, representing an indicative premium of around 18.95%.

At a GMP of ₹212, the indicative premium for one retail lot of 12 shares would be approximately ₹2,544. However, GMP is unofficial and can change frequently. It should not be considered a guaranteed listing gain or listing price.

Check the latest Jio Platforms IPO GMP, Kostak Rates and Subject to Sauda Price here.

Jio Platforms IPO Subscription Status

The Jio Platforms IPO has not yet opened for public subscription. The IPO will open on 21-October-2026 and close on 23-October-2026.

Anchor investors will be able to participate on 19-October-2026. The live category-wise subscription figures will be updated on this page once bidding begins.

The subscription figures will be updated once the issue opens. The RIL shareholder reservation is available only to eligible shareholders meeting the applicable record-date requirements.

Jio Platforms IPO Prospectus

The Jio Platforms IPO Prospectus is available through the Jio Platforms, BSE and SEBI websites. The Red Herring Prospectus was filed with the Registrar of Companies on 15-October-2026. Please click here to download the Jio Platforms IPO Prospectus.

Jio Platforms IPO Allotment Date & Details

The above allotment, refund, demat credit and listing dates are indicative and subject to the final issue timetable. Current IPO sources show 26 October for allotment, 27 October for credit/refunds and 28 October for listing.

Jio Platforms IPO Registrar

KFin Technologies Limited

Selenium Tower-B
Plot No. 31 & 32, Gachibowli
Financial District, Nanakramguda
Serilingampally, Hyderabad 500 032
Telangana, India

Tel: +91 40 6716 2222 / 1800 309 4001

E-mail: jioplatforms.ipo@kfintech.com

Website: www.kfintech.com

Investor Grievance E-mail: einward.ris@kfintech.com

Jio Platforms IPO Contact Address

Jio Platforms Limited

Registered Office: Office-101, Saffron,
Nr. Centre Point, Panchwati 5 Rasta,
Ambawadi,
Ahmedabad, Gujarat – 380006

Phone: +91 22 7967 0000

Email: jpl.investorrelations@jio.com

Website: www.jio.com

Jio Platforms IPO Lead Managers

• Kotak Mahindra Capital Company Limited
• Morgan Stanley India Company Private Limited
• BofA Securities India Limited
• Axis Capital Limited
• BNP Paribas
• Citigroup Global Markets India Private Limited
• CLSA India Private Limited
• DAM Capital Advisors Limited
• Goldman Sachs (India) Securities Private Limited
• HDFC Bank Limited
• HSBC Securities and Capital Markets (India) Private Limited
• ICICI Securities Limited
• IIFL Capital Services Limited
• Jefferies India Private Limited
• JM Financial Limited
• J.P. Morgan India Private Limited
• SBI Capital Markets Limited
• UBS Securities India Private Limited
• 360 ONE WAM Limited

The post Jio Platforms IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

There are three basic categories in Nityas Gems and Jewellery IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail.

Nityas Gems and Jewellery are engaged in the design, manufacturing and sale of lab-grown diamond studded gold jewellery in India, operating through an integrated business model comprising (i) business-to-business (“B2B”) manufacturing and distribution to organized retailers, standalone retailers and wholesalers, to support their inventory and design requirements; and (ii) direct-to-consumer (“D2C”) omnichannel retail operations through our subsidiary, Ayaani Diamonds and Jewellery Private Limited (“Ayaani”).

They offer a range of lab-grown diamond studded gold jewellery products across categories such as rings, earrings, pendants, bracelets, mangalsutras, nose pins, necklaces, cufflings and bangles, across daily wear, occasion-based, men’s jewellery and customized segments.

They prominent B2B customers include established and organised jewellery retailers such as ‘GIVA’, ‘Palmonas’, ‘ONYA’, and ‘Ladia Diamonds’, among others.

They also cater standalone retailers and wholesalers under B2B vertical.

They supply lab-grown diamond studded gold jewellery to such customers based on designs developed by them.

Nityas Gems and Jewellery IPO Promoters

Rajnikant Lallubhai Chanchad, Sonalben Rajnikant Chanchad and Savaliya Dhruv Janakbhai are the promoters of the company.

Nityas Gems and Jewellery IPO Date, Details & Price Band

The Nityas Gems and Jewellery IPO Price Band, IPO Dates, Market lot and other details are mentioned in the table below.

Nityas Gems and Jewellery IPO Market Lot

The Nityas Gems and Jewellery IPO minimum market lot is 200 shares, with a ₹15,000 application amount.

Restated Consolidated Financial Information (Amt. in Crore)

Nityas Gems and Jewellery IPO GMP & Grey Market Premium

The Nityas Gems and Jewellery IPO GMP (Grey Market Premium) has started today. Check the Latest Nityas Gems and Jewellery IPO GMP, Kostak Rates, and Subject to Sauda Price here.

Nityas Gems and Jewellery IPO Prospectus

The Nityas Gems and Jewellery IPO Prospectus is Available on the Nityas Gems and Jewellery/BSE and SEBI websites, as well as on our Portal. Please click here to download the Nityas Gems and Jewellery IPO Prospectus.

Nityas Gems and Jewellery IPO Allotment Date & Details

Nityas Gems and Jewellery IPO Registrar

Bigshare Services Private Limited
Office No. S6-2, 6th Floor Pinnacle Business Park
Next to Ahura Center Mahakali Caves Road
Andheri East Mumbai – 400 093 Maharashtra, India
Telephone: +91 22 6263 8200
E-mail: ipo@bigshareonline.com
Investor Graiviance Email: investor@bigshareonline.com
Website: www.bigshareonline.com
Contact Person: Vikram Morbale
SEBI Registration No.: INR000001385

Nityas Gems and Jewellery IPO Contact Address

Nityas Gems and Jewellery Ltd
Address : Sector-1, 6th & 7th Floor,
Ratih House SY-376, TPS 4, PI-7,Paiki Part-B,
Parshottam Farm Compound Opp. Podar Arcade,
Varachha Road, A. K. Road Surat,
Gujarat, 395008
+91 70462 19807
cs@nityas.in

Nityas Gems and Jewellery IPO Lead Managers

Choice Capital Advisors Private Limited
Sunil Patodia Tower, Plot No. 156-158
J.B. Nagar, Andheri (East)
Mumbai – 400 099, Maharashtra, India
Telephone: +91 22 6707 9999 / 7919
Email: ngjl.ipo@choiceindia.com
Investor Grievance Email:
investorgrievances_advisors@choiceindia.com
Website: www.choiceindia.com/merchant-investment-banking
Contact Person: Nimisha Joshi / Yogesh Mody
SEBI Registration No: INM000011872

The post Nityas Gems and Jewellery IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

There are three basic categories in Vishal Nirmiti IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail.

Vishal Nirmiti are a civil engineering, manufacturing and construction company, primarily engaged in the business of manufacturing and dealing of Pre-Stressed Concrete (PSC) sleepers for railways, pre cast and prestressed concrete products for various applications and are also into fabrication and erection of Mild Steel Pipes (MS Pipes), MS Liner, and Penstock Pipes for Pumped Storage Project (PSP).

They provide engineering, procurement, infrastructure and construction services for railway infrastructure and various civil engineering, irrigation and infrastructure development projects across sectors such as
railways, renewable power and industrial sectors. Our business is divided into two segments, namely, (a) Manufacturing segment and (b) Services segment.

They are currently present in the states of Maharashtra, Madhya Pradesh, Gujarat, Himachal Pradesh, Odisha, Delhi, Punjab and Karnataka wherein we have units either owned by us, or leased or allotted or licensed for job work purposes catering to our clients and business requirement.

Vishal Nirmiti IPO Promoters

Brij B Tapadiya, Ajay Bhagwandas Tapadiya, Pavan Vithaldas Tapadiya, Akhil Ranchod Tapadiya, Naveen Tapadiya, Rajendrakumar Badrinarayan Tapadiya, Suyash Vithaldas Tapadiya, Vedant Tapadiya and Keshav Tapadiya are the promoters of the company.

Vishal Nirmiti IPO Date, Details & Price Band

The Vishal Nirmiti IPO Price Band, IPO Dates, Market lot and other details are mentioned in the table below.

Vishal Nirmiti IPO Market Lot

The Vishal Nirmiti IPO minimum market lot is 68 shares, with a ₹14,960 application amount.

Restated Consolidated Financial Information (Amt. in Crore)

Vishal Nirmiti IPO GMP & Grey Market Premium

The Vishal Nirmiti IPO GMP (Grey Market Premium) has started today. Check the Latest Vishal Nirmiti IPO GMP, Kostak Rates, and Subject to Sauda Price here.

Vishal Nirmiti IPO Prospectus

The Vishal Nirmiti IPO Prospectus is Available on the Vishal Nirmiti/BSE and SEBI websites, as well as on our Portal. Please click here to download the Vishal Nirmiti IPO Prospectus.

Vishal Nirmiti IPO Allotment Date & Details

Vishal Nirmiti IPO Registrar

MUFG Intime India Private Limited
(formerly known as Link Intime India Private Limited)
Address: C-101, Embassy 247, L.B.S Marg, Vikhroli (West),
Mumbai – 400 083 Maharashtra, India
Tel: +91 810 811 4949
E-mail: vishalnirmiti.ipo@in.mpms.mufg.com
Website: www.in.mpms.mufg.com
Investor grievance e-mail: vishalnirmiti.ipo@in.mpms.mufg.com
Contact person: Shanti Gopalkrishnan
SEBI Registration Number: INR000004058

Vishal Nirmiti IPO Contact Address

Vishal Nirmiti Ltd
Address : 303, 17 Elphinstone House,
Marzban Road, New Empire Cinema,
Fort Mumbai, Maharashtra, 400001
+91 9823877359
ipo@vishalnirmiti.com

Vishal Nirmiti IPO Lead Managers

Saffron Capital Advisors Private Limited
605, Center Point, 6th floor, J. B. Nagar, Andheri Kurla Road,
Andheri (East), Mumbai – 400 059, Maharashtra, India.
Tel: +91 22 4973 0394
E-mail: ipos@saffronadvisor.com
Website: www.saffronadvisor.com
Investor grievance e-mail:investorgrievance@saffronadvisor.com
Contact person: Pratibha Joshi/ Satej Darde
SEBI Registration Number: INM000011211

The post Vishal Nirmiti IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

There are three basic categories in Shah Investor’s Home IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail.

Shah Investor’s Home is a retail brokerage company that offers a range of services covering equity brokerage services and derivatives brokerage services, with over three decades of experience.

Their services facilitate the buying and selling of financial products such as equities, IPO investing, mutual fund distribution, and other securities. While our core operations include equity and derivatives brokerage, we primarily focus on providing secondary market brokering services to retail customers, including resident and non-resident Indians. In addition to executing buy and sell orders, our business includes mutual fund distribution, margin funding, and stock lending and borrowing services, carried out under the brand name “Shah Investors”.

They have served over 1,00,000 demat accounts, with more than 38,000 active clients and partnerships with over 181 authorised persons.

They conduct their operations through 11 branches in India, located in Mumbai, Ahmedabad, Vadodara, Junagadh, Gandhinagar and Rajkot.

Shah Investor’s Home IPO Promoters

Upendra Trikamlal Shah, Purnima Upendra Shah, Tanmay Upendra Shah and Trupti Utpal Shah are the promoters of the company.

Shah Investor’s Home IPO Date, Details & Price Band

The Shah Investor’s Home IPO Price Band, IPO Dates, Market lot and other details are mentioned in the table below.

Shah Investor’s Home IPO Market Lot

The Shah Investor’s Home IPO minimum market lot is 85 shares, with a ₹14,873 application amount.

Restated Consolidated Financial Information (Amt. in Crore)

Shah Investor’s Home IPO GMP & Grey Market Premium

The Shah Investor’s Home IPO GMP (Grey Market Premium) has started today. Check the Latest Shah Investor’s Home IPO GMP, Kostak Rates, and Subject to Sauda Price here.

Shah Investor’s Home IPO Prospectus

The Shah Investor’s Home IPO Prospectus is Available on the Shah Investor’s Home/BSE and SEBI websites, as well as on our Portal. Please click here to download the Shah Investor’s Home IPO Prospectus.

Shah Investor’s Home IPO Allotment Date & Details

Shah Investor’s Home IPO Registrar

MUFG Intime India Private Limited (formerly Link Intime India Private
Limited)
C-101, 1stFloor, 247 Park Lal Bahadur Shastri Marg,
Vikhroli (West), Mumbai – 400 083, Maharashtra, India
Telephone Number: +91 8108114949
E-mail: shahInvestors.ipo@in.mpms.mufg.com
Investor Grievance E-mail: shahInvestors.ipo@in.mpms.mufg.com
Website: www.in.mpms.mufg.com
Contact Person: Shanti Gopalkrishnan
SEBI Registration Number: INR000004058

Shah Investor’s Home IPO Contact Address

Shah Investor’s Home Ltd
Address : 810, X-Change Plaza DSCCSL (53E),
Road 5E Block 53, Zone 5,
Gift City Gandhinagar,
Gujarat, 382050
+91 9904053335
company.secretary@sihl.in

Shah Investor’s Home IPO Lead Managers

Beeline Capital Advisors Private Limited
B 1311 – 1314 Thirteenth Floor Shilp Corporate Park
Rajpath Rangoli Road Thaltej Ahmedabad – 380054,
Gujarat, India
Telephone Number: +91 79 4918 5784
E-mail: mb@beelinemb.com
Investor Grievance E-mail: ig@beelinemb.com
Website: https://beelinemb.com/
Contact Person: Nikhil Shah
SEBI Registration No.: INM000012917

The post Shah Investor’s Home IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.

There are three basic categories in SRIT India IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail.

SRIT India IPO are a Bengaluru-headquartered Information Technology and Information Technology enabled Services (“IT/ITeS”) solutions company offering digital solutions and automations of systems through custom application development and integration services.

They offer a diversified suite of technology-led services across multiple verticals, serving Government and Enterprise customers.

The service offerings cover the design, implementation, operation, and maintenance of digital platforms, network infrastructure, and enterprise systems, supported by software development solutions, system integration,
automations, customizations and managed service capabilities.

The activities are organised across three verticals: (i) healthcare, (ii) electronic governance, and (iii) telecommunications and broadband.

SRIT India IPO Promoters

Vipul Nagpal, Garima Nagpal, Vardaan Nagpal, Vipul Family Trust and Garima Family Trust are the promoters of the company.

SRIT India IPO Date, Details & Price Band

The SRIT India IPO Price Band, IPO Dates, Market lot and other details are mentioned in the table below.

SRIT India IPO Market Lot

The SRIT India IPO minimum market lot is 115 shares, with a ₹14,950 application amount.

Restated Consolidated Financial Information (Amt. in Crore)

SRIT India IPO GMP & Grey Market Premium

The SRIT India IPO GMP (Grey Market Premium) has started today. Check the Latest SRIT India IPO GMP, Kostak Rates, and Subject to Sauda Price here.

SRIT India IPO Prospectus

The SRIT India IPO Prospectus is Available on the SRIT India/BSE and SEBI websites, as well as on our Portal. Please click here to download the SRIT India IPO Prospectus.

SRIT India IPO Allotment Date & Details

SRIT India IPO Registrar

KFin Technologies Limited
Selenium Tower-B, Plot No. 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500032, Telangana
Tel: 040-67162222/18003094001
E-mail: srit.ipo@kfintech.com
Investor grievance E-mail: einward.ris@kfintech.com
Website: www.kfintech.com
Contact person: M Murali Krishna
SEBI Registration No: INR000000221

SRIT India IPO Contact Address

SRIT India Ltd
Address : SRIT House, #113/1B
ITPL Main Road
Kundalahalli
Bengaluru, Karnataka, 560037
+91-80419 51999
cs.nidhi@sritindia.com

SRIT India IPO Lead Managers

Choice Capital Advisors Private Limited
Sunil Patodia Tower, Plot No. 156-158, J.B. Nagar,
Andheri (East), Mumbai City, Mumbai – 400099,
Maharashtra, India.
Tel: +91 22 6707 9999 (7919)
E-mail: sil.ipo@choiceindia.com
Investor Grievance E-mail:
investorgrievances_advisors@choiceindia.com
Website: www.choiceindia.com/merchant-investment-banking
Contact person: Nimisha Joshi/ Anuj Killa
SEBI Registration No.: INM000011872

The post SRIT India IPO Date, Price, GMP, Review, Details appeared first on IPO Wala.